Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NERV Minerva Neurosciences

盘前交易 11-22 04:38:38 EST

2.21

+0.09

+4.25%

最高2.23	最低2.14	成交量1.73万
今开2.15	昨收2.12	日振幅4.24%
总市值1,546万	流通市值1,202万	总股本699.34万
成交额3.78万	换手率0.32%	流通股本543.70万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NERV","market":"US","secType":"STK","nameCN":"Minerva Neurosciences","latestPrice":2.21,"timestamp":1732222800000,"preClose":2.12,"halted":0,"volume":17322,"delay":0,"floatShares":5437017,"shares":6993406,"eps":-0.441772,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.09,"latestTime":"11-22 04:38:38 EST","open":2.145,"high":2.2299,"low":2.14,"amount":37779.967951,"amplitude":0.042406,"askPrice":2.8,"askSize":100,"bidPrice":1.96,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.441772,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732285800000},"adr":0,"listingDate":1404187200000,"adjPreClose":2.16,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.14,"preClose":2.21,"latestTime":"19:46 EST","volume":404,"amount":864.73,"timestamp":1732236416410},"volumeRatio":1.3508589997896212,"impliedVol":5.4722,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/NERV","defaultTab":"news","newsList":[{"id":"2485955418","title":"Minerva Neurosciences, Inc盘中异动 大幅拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485955418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485955418?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:47","pubTimestamp":1732200422,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时47分，Minerva Neurosciences, Inc股票出现异动，股价急速拉升5.18%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Conduit Pharmaceuticals Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Biodexa Pharmaceuticals Plc、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为316.26%、59.95%、47.92%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为78.05%、76.00%、68.00%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122470295be4ef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122470295be4ef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2484603887","title":"Minerva Neurosciences, Inc盘中异动 股价大跌5.90%报2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484603887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484603887?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:24","pubTimestamp":1731947096,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日00时24分，Minerva Neurosciences, Inc股票出现异动，股价大幅下挫5.90%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Hcw Biologics Inc.、冠科美博、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃，换手率分别为878.22%、562.18%、504.51%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博，振幅分别为241.00%、129.51%、75.18%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119002456abccdded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119002456abccdded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2483358303","title":"Minerva Neurosciences, Inc盘中异动 股价大跌8.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483358303?lang=zh_cn&edition=full","pubTime":"2024-11-16 02:19","pubTimestamp":1731694787,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日02时19分，Minerva Neurosciences, Inc股票出现异动，股价急速下挫8.14%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为3.55%。其相关个股中，Cero Therapeutics Holdings, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为4405.11%、706.34%、567.44%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为134.58%、129.73%、110.59%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116021947a23bca29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116021947a23bca29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2482422430","title":"Minerva Neurosciences, Inc2024财年第三财季实现净利润22.51百万美元，同比增加387.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482422430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482422430?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:02","pubTimestamp":1731168124,"startTime":"0","endTime":"0","summary":"11月10日，Minerva Neurosciences, Inc公布财报，公告显示公司2024财年第三财季净利润为22.51百万美元，同比增加387.85%；其中营业收入为0.00美元，每股基本收益为2.97美元。机构评级：截至2024年11月10日，当前有1家机构对Minerva Neurosciences, Inc目标价做出预测，其中目标均价为5.00美元，其中最低目标价为5.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000225a2278624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000225a2278624&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV"],"gpt_icon":0},{"id":"2481661473","title":"Minerva Neurosciences Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481661473","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481661473?lang=zh_cn&edition=full","pubTime":"2024-11-06 12:59","pubTimestamp":1730869183,"startTime":"0","endTime":"0","summary":"   * Minerva Neurosciences Inc   报告，截至9月30日的季度调整后每股亏损54美分，高于去年同期的每股收益1.03美元。* 报告收入为零，分析师预期为零。* Minerva Neurosciences Inc 报告的本季度每股收益为 2.97 美元。* 公司报告的季度净收入为 2251 万美元。* Minerva Neurosciences Inc 本季度股价下跌了 13.1%，今年迄今为止下跌了 62.3%。* 在过去 30 天内，没有覆盖该公司的分析师对盈利预期进行修正。华尔街对 Minerva Neurosciences Inc 的 12 个月目标价中位数为 5.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Minerva Neurosciences Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2481868591","title":"Minerva Neurosciences, Inc盘中异动 早盘大幅上涨5.31%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481868591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481868591?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:56","pubTimestamp":1730818606,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时56分，Minerva Neurosciences, Inc股票出现异动，股价大幅上涨5.31%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Elevai Labs, Inc.较为活跃，换手率分别为4351.29%、1419.29%、499.30%，振幅较大的相关个股有Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为67.30%、42.31%、29.27%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105225646a218d1a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105225646a218d1a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2480581600","title":"Minerva Neurosciences, Inc盘中异动 股价大跌5.00%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581600?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730702,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Minerva Neurosciences, Inc股票出现波动，股价快速下挫5.00%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为233.32%、124.60%、40.93%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.、Tenaya Therapeutics, Inc.，振幅分别为29.83%、11.39%、9.28%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223142a215493e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223142a215493e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2480510428","title":"Minerva Neurosciences, Inc盘中异动 下午盘急速上涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480510428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480510428?lang=zh_cn&edition=full","pubTime":"2024-11-02 03:28","pubTimestamp":1730489304,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日03时28分，Minerva Neurosciences, Inc股票出现异动，股价急速上涨6.03%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Revolution Medicines Inc C/Wts 17/12/2026 、Athira Pharma, Inc.涨幅较大，Theriva Biologics, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为3670.72%、941.76%、892.52%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ，振幅分别为122.67%、101.75%、62.87%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102032824971a3ed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102032824971a3ed8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2480988107","title":"Minerva Neurosciences Inc    预计每股亏损 1.01 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480988107","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480988107?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:04","pubTimestamp":1730469846,"startTime":"0","endTime":"0","summary":"   * Minerva Neurosciences Inc    预计在11月5日公布截至2024年9月30日的财报时，季度营收将没有变化(预计)。*    * LSEG 的分析师平均预计 Minerva Neurosciences Inc 每股亏损 1.01 美元。* 分析师对该公司股票的评级为 \"持有\"。* 华尔街对 Minerva Neurosciences Inc 的 12 个月目标价中位数为 5.00 美元，高于其上一次收盘价 2.40 美元。11月1日 - 本摘要于北京时间 11 月 1 日 14:04 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Minerva Neurosciences Inc    预计每股亏损 1.01 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV"],"gpt_icon":0},{"id":"2476215176","title":"Minerva Neurosciences, Inc盘中异动 快速下挫5.04%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476215176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476215176?lang=zh_cn&edition=full","pubTime":"2024-10-19 03:45","pubTimestamp":1729280716,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日03时45分，Minerva Neurosciences, Inc股票出现异动，股价急速下跌5.04%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Biovie Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1634.26%、1008.98%、647.61%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Biovie Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为255.36%、159.82%、113.50%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019034516971a12d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019034516971a12d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2472963655","title":"Minerva Neurosciences, Inc盘中异动 早盘快速拉升7.00%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472963655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472963655?lang=zh_cn&edition=full","pubTime":"2024-10-04 22:31","pubTimestamp":1728052304,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日22时31分，Minerva Neurosciences, Inc股票出现异动，股价大幅上涨7.00%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Geovax Labs Inc C/Wts 29/09/2025、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为14138.87%、47.42%、35.22%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Aditxt, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为58.64%、47.42%、38.39%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004223144ab67be59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004223144ab67be59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2460666650","title":"Minerva Neurosciences, Inc盘中异动 大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460666650","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460666650?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:34","pubTimestamp":1724096065,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时34分，Minerva Neurosciences, Inc股票出现波动，股价大幅拉升5.10%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Nucana Plc涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为9425.06%、3890.54%、1330.17%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为448.55%、220.18%、198.02%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003342597199318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003342597199318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2459404596","title":"Minerva Neurosciences, Inc盘中异动 急速下挫5.30%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459404596","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459404596?lang=zh_cn&edition=full","pubTime":"2024-08-16 03:18","pubTimestamp":1723749530,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日03时18分，Minerva Neurosciences, Inc股票出现异动，股价大幅下挫5.30%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为11090.24%、2351.65%、659.70%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cingulate Inc.、Nutriband Inc C/Wts ，振幅分别为163.33%、162.60%、115.79%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081603185097198ddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081603185097198ddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2458826776","title":"Minerva Neurosciences, Inc2024财年第二财季实现净利润-8.23百万美元，同比减少32.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458826776","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458826776?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:19","pubTimestamp":1723306781,"startTime":"0","endTime":"0","summary":"8月11日，Minerva Neurosciences, Inc公布财报，公告显示公司2024财年第二财季净利润为-8.23百万美元，同比减少32.96%；其中营业收入为0.00美元，每股基本收益为-1.09美元。机构评级：截至2024年8月11日，当前有1家机构对Minerva Neurosciences, Inc目标价做出预测，其中目标均价为7.00美元，其中最低目标价为7.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110019469f204aa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408110019469f204aa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV"],"gpt_icon":0},{"id":"2458519363","title":"Minerva Neurosciences, Inc盘中异动 急速跳水5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458519363","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458519363?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:43","pubTimestamp":1723221832,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时43分，Minerva Neurosciences, Inc股票出现波动，股价急速下挫5.40%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为2.00%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大，Azitra Inc、Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为434.56%、96.44%、66.97%，振幅较大的相关个股有Azitra Inc、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为90.93%、62.57%、37.04%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810004352af96d6f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810004352af96d6f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2457006468","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457006468","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457006468?lang=zh_cn&edition=full","pubTime":"2024-08-07 04:00","pubTimestamp":1722974458,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日04时00分，Minerva Neurosciences, Inc股票出现异动，股价急速拉升5.00%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1462.63%、1424.15%、587.91%，振幅较大的相关个股有Vbi Vaccines, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Alpha Tau Medical Ltd C/Wts ，振幅分别为168.52%、81.76%、78.49%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807040058af9637de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807040058af9637de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NERV"],"gpt_icon":0},{"id":"2457040956","title":"Minerva Neurosciences Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457040956","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457040956?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951088,"startTime":"0","endTime":"0","summary":"   * Minerva Neurosciences Inc   报告了截至1月份的季度调整后每股亏损1.09美元，高于去年同期的每股亏损1.12美元。* 报告收入为零，分析师预期为零。* Minerva Neurosciences Inc 报告的本季度每股收益为亏损 1.09 美元。* 该公司当季亏损 823 万美元。* Minerva Neurosciences Inc 的股价本季度下跌了 12.2%，今年迄今为止下跌了 54.5%。* 在过去 30 天内，没有覆盖该公司的分析师对盈利预期进行修正。华尔街对 Minerva Neurosciences Inc 的 12 个月目标价中位数为 7.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Minerva Neurosciences Inc 报告截至一月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2455340101","title":"Minerva Neurosciences Inc    预计每股亏损 97 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455340101","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455340101?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:58","pubTimestamp":1722434291,"startTime":"0","endTime":"0","summary":"   * Minerva Neurosciences Inc    预计在8月2日公布截至2024年6月30日的财报时，季度收入将没有变化(预计)。*    * LSEG 的分析师平均预计 Minerva Neurosciences Inc 每股亏损 97 美分。* 分析师对该公司股票的评级为 \"持有\"。* 华尔街对 Minerva Neurosciences Inc 的 12 个月目标价中值为 7.00 美元，高于其上一次收盘价 3.03 美元。7月31日 - 本摘要于北京时间7月31日13:58由机器生成。除非另有说明，所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV"],"gpt_icon":0},{"id":"2455607149","title":"Minerva Neurosciences, Inc盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455607149","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455607149?lang=zh_cn&edition=full","pubTime":"2024-07-31 03:56","pubTimestamp":1722369362,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日03时56分，Minerva Neurosciences, Inc股票出现波动，股价急速拉升5.47%。Minerva Neurosciences, Inc股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Imunon, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Celularity Inc C/Wts 16/07/2026 涨幅较大，Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为2006.39%、1602.60%、1468.27%，振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.，振幅分别为78.15%、65.88%、59.59%。Minerva Neurosciences, Inc公司简介：Minerva Neurosciences Inc 是一家处于临床阶段的生物制药公司。目标疾病包括精神分裂症、失眠症、抑郁障碍和帕金森病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073103560296821a9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073103560296821a9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NERV","BK4139"],"gpt_icon":0},{"id":"2454400303","title":"Minerva Neurosciences Inc    预计每股亏损 97 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2454400303","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454400303?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:51","pubTimestamp":1722001870,"startTime":"0","endTime":"0","summary":"   * Minerva Neurosciences Inc    预计在7月30日发布业绩报告时，季度营收将保持不变。*    * LSEG 的分析师平均预计 Minerva Neurosciences Inc 每股亏损 97 美分。* 分析师对该公司股票的评级为 \"持有\"。* 华尔街对 Minerva Neurosciences Inc 的 12 个月目标价中值为 7.00 美元，高于其上一次收盘价 3.12 美元。7月26日 - 本摘要于北京时间 7 月 26 日 13:51 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NERV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.minervaneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.0474},{"period":"1month","weight":-0.1089},{"period":"3month","weight":-0.1597},{"period":"6month","weight":-0.0948},{"period":"1year","weight":-0.5598},{"period":"ytd","weight":-0.6407}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Minerva Neurosciences, Inc.在Cyrenaic制药公司的名义下根据特拉华州法律于2007年4月23日成立。2013年11月，它合并了Sonkei制药有限公司以及合并后的公司更名为密涅瓦神经科学有限公司。作为合并，或Sonkei合并的结果，该公司有权在全球范围内开发，销售和进口MIN- 101和MIN -117，根据与三菱田边制药公司许可协议的权利，不包括亚洲大部分地区。公司通过收购Mind-NRG SA（或Mind-NRG）的股份，在2014年2月进一步扩大其产品候选组合，它具有独家开发和商业化MIN- 301，或 Mind-NRG 收购的权利。公司是一家临床阶段的生物制药公司，专注于发展和商业化候选产品的组合来治疗病人中枢神经系统（或 CNS）疾病。公司的主导候选产品是MIN- 101——它正在开发用于治疗精神分裂症的治疗化合物，和MIN -117 ——公司正在开发用于治疗重性抑郁障碍的痛苦治疗化合物（或MDD ）。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.093479},{"month":2,"riseRate":0.2,"avgChangeRate":-0.109643},{"month":3,"riseRate":0.3,"avgChangeRate":-0.000761},{"month":4,"riseRate":0.5,"avgChangeRate":0.05689},{"month":5,"riseRate":0.6,"avgChangeRate":0.169154},{"month":6,"riseRate":0.6,"avgChangeRate":0.064983},{"month":7,"riseRate":0.3,"avgChangeRate":-0.047781},{"month":8,"riseRate":0.454545,"avgChangeRate":0.30882},{"month":9,"riseRate":0.363636,"avgChangeRate":0.005596},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.224456},{"month":11,"riseRate":0.545455,"avgChangeRate":0.084158},{"month":12,"riseRate":0.4,"avgChangeRate":-0.089821}],"exchange":"NASDAQ","name":"Minerva Neurosciences","nameEN":"Minerva Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Minerva Neurosciences,NERV,Minerva Neurosciences股票,Minerva Neurosciences股票老虎,Minerva Neurosciences股票老虎国际,Minerva Neurosciences行情,Minerva Neurosciences股票行情,Minerva Neurosciences股价,Minerva Neurosciences股市,Minerva Neurosciences股票价格,Minerva Neurosciences股票交易,Minerva Neurosciences股票购买,Minerva Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Minerva Neurosciences(NERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Minerva Neurosciences(NERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况